Apollo Strategic Growth Capital II (APGB) 10-Q 12 Nov 21 2021 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2021	Nov. 12, 2021
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2021
Entity File Number	001-40018
Entity Registrant Name	APOLLO STRATEGIC GROWTH CAPITAL II
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-0598286
Entity Address, Address Line One	9 West 57th Street, 43rd Floor
Entity Address, City or Town	New York
Entity Address State Or Province	NY
Entity Address, Postal Zip Code	10019
City Area Code	212
Local Phone Number	515-3200
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001838337
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false
Transition Report	false
Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.00025 par value, and one-fifth of one warrant
Trading Symbol	APGB.U
Security Exchange Name	NYSE
Class A Common Stock
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary share
Trading Symbol	APGB
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		69,000,000
Warrants included as part of the units
Document Information [Line Items]
Title of 12(b) Security	Warrants included as part of the units
Trading Symbol	APGB WS
Security Exchange Name	NYSE
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		17,250,000

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 1,585,629
Prepaid expenses	1,108,409	$ 1,704
Deferred offering costs		448,186
Total current assets	2,694,038	449,890
Investments held in Trust Account	690,063,006
Total assets	692,757,044	449,890
Current liabilities:
Accounts payable and accrued expenses	4,045,406	398,000
Accrued offering costs		50,186
Note payable - sponsor	3,000,000
Total current liabilities	7,045,406	448,186
Derivative warrant liability	22,527,182	0
Deferred underwriting compensation	24,150,000
Total liabilities	53,722,588	448,186
Commitments and contingencies (Note 7)
Shareholders' equity:
Preferred shares, $0.00025 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital		32,529
Accumulated deficit	(50,966,622)	(31,903)
Total shareholders' (deficit) equity	(50,965,544)	1,704
Total liabilities, temporary equity and shareholders' equity	692,757,044	449,890
Class A Common Stock
Current liabilities:
Class A ordinary shares subject to possible redemption (69,000,000 and 0 shares at approximately $10.00 per share as of September 30, 2021 and December 31, 2020, respectively)	690,000,000
Class A Common Stock Subject to Redemption
Current liabilities:
Class A ordinary shares subject to possible redemption (69,000,000 and 0 shares at approximately $10.00 per share as of September 30, 2021 and December 31, 2020, respectively)	690,000,000
Class B Common Stock
Shareholders' equity:
Common stock	$ 1,078	$ 1,078

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Preference stock, par value, (per share)	$ 0.00025	$ 0.00025
Preference stock, shares authorized	1,000,000	1,000,000
Preference stock, shares issued	0	0
Preference stock, shares outstanding	0	0
Class A Common Stock
Common shares, par value, (per share)	$ 0.00025	$ 0.00025
Common shares, shares authorized	180,000,000	180,000,000
Common shares, shares issued	0	0
Common shares, shares outstanding	0	0
Temporary equity, shares outstanding	69,000,000	69,000,000
Class A Common Stock Subject to Redemption
Temporary equity, shares issued	69,000,000	0
Temporary equity, shares outstanding	69,000,000	0
Purchase price, per unit	$ 10	$ 10
Class A Common Stock Not Subject to Redemption
Temporary equity, shares outstanding	69,000,000
Class B Common Stock
Common shares, par value, (per share)	$ 0.0000625	$ 0.0000625
Common shares, shares authorized	46,000,000	46,000,000
Common shares, shares issued	17,250,000	17,250,000
Common shares, shares outstanding	17,250,000	17,250,000

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
REVENUE	$ 0	$ 0	$ 0	$ 0
EXPENSES
Administration fee - related party	50,001		126,788
General and administrative	1,614,271		4,730,014	1,854
TOTAL EXPENSES	1,664,272		4,856,802	1,854
OTHER INCOME (EXPENSES)
Investment income earned on investment held in Trust Account	8,880		63,006
Interest expense	(528)		(1,070)
Transaction costs allocable to warrant liability			(1,494,398)
Change in fair value of derivative warrants	8,212,338		19,385,278
TOTAL OTHER INCOME (EXPENSES) - NET	8,220,690		17,952,816
Net income (loss) attributable to ordinary shares	$ 6,556,418	$ 0	$ 13,096,014	$ (1,854)
Class A Common Stock
OTHER INCOME (EXPENSES)
Weighted average shares outstanding, basic and diluted	69,000,000		69,000,000
Basic and diluted net income (loss) per ordinary share	$ 0.08	$ 0	$ 0.15	$ 0
Class B Common Stock
OTHER INCOME (EXPENSES)
Weighted average shares outstanding, basic and diluted	17,250,000	15,000,000	17,250,000	15,000,000
Basic and diluted net income (loss) per ordinary share	$ 0.08	$ 0	$ 0.15	$ 0

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)	Common StockClass B Common Stock	Additional Paid-in Capital	Retained Earnings	Total
Balance at the beginning at Dec. 31, 2019	$ 1,078	$ 30,825	$ (30,049)	$ 1,854
Balance at the beginning (in shares) at Dec. 31, 2019	17,250,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Capital contributions		1,704		1,704
Net loss			(1,854)	(1,854)
Balance at the end at Sep. 30, 2020	$ 1,078	32,529	(31,903)	1,704
Balance at the end (in shares) at Sep. 30, 2020	17,250,000
Balance at the beginning at Jun. 30, 2020	$ 1,078	32,529	(31,903)	1,704
Balance at the beginning (in shares) at Jun. 30, 2020	17,250,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ 0	0	0	0
Balance at the end at Sep. 30, 2020	$ 1,078	32,529	(31,903)	1,704
Balance at the end (in shares) at Sep. 30, 2020	17,250,000
Balance at the beginning at Dec. 31, 2020	$ 1,078	32,529	(31,903)	1,704
Balance at the beginning (in shares) at Dec. 31, 2020	17,250,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A ordinary shares to redemption amount		$ (32,529)	(64,030,733)	(64,063,262)
Net loss			13,096,014	13,096,014
Balance at the end at Sep. 30, 2021	$ 1,078		(50,966,622)	(50,965,544)
Balance at the end (in shares) at Sep. 30, 2021	17,250,000
Balance at the beginning at Jun. 30, 2021	$ 1,078		(57,523,040)	(57,521,962)
Balance at the beginning (in shares) at Jun. 30, 2021	17,250,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			6,556,418	6,556,418
Balance at the end at Sep. 30, 2021	$ 1,078		$ (50,966,622)	$ (50,965,544)
Balance at the end (in shares) at Sep. 30, 2021	17,250,000

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2020
Cash Flows From Operating Activities:
Net income (loss)		$ 13,096,014	$ (1,854)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Investment income earned on investment held in Trust Account	$ (8,880)	(63,006)
Change in fair value of derivative liabilities	(8,212,338)	(19,385,278)
Transaction costs allocable to warrant liability		1,494,398
Changes in operating assets and liabilities:
Prepaid expenses		(1,106,705)	(1,854)
Accounts payable and accrued expenses		4,273,415
Net Cash Used In Operating Activities		(1,691,162)
Cash Flows From Investing Activities:
Cash deposited into Trust Account		(690,000,000)
Net Cash Used In Investing Activities		(690,000,000)
Cash Flows From Financing Activities:
Proceeds from sale of Units in Public Offering, net of underwriting fee		674,903,096
Proceeds from sale of Private Placement Warrants		15,600,000
Proceeds from Sponsor note		3,000,000
Repayment of advances from Sponsor		(226,305)
Net Cash Provided By Financing Activities		693,276,791
Net change in cash		1,585,629
Cash at beginning of period		0	0
Cash at end of period	$ 1,585,629	1,585,629	0
Supplemental disclosure of non-cash financing activities:
Deferred underwriters' commissions charged to additional paid-in capital in connection with the Public Offering		24,150,000
Initial Classification of Class A ordinary shares subject to possible redemption		690,000,000
Initial classification of fair value of Public warrants		41,912,460
Operating costs paid by related party which were charged to additional paid-in capital		0	$ 1,704
Deferred offering costs paid by related party		$ 626,009

DESCRIPTION OF ORGANIZATION, BU

DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN	9 Months Ended
	Sep. 30, 2021
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN	NOTE 1 — DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN Organizational and General Apollo Strategic Growth Capital II (formerly known as APH I (Sub I), Ltd.) (the “Company”) was initially incorporated in Cayman Islands on October 10, 2008 under the name of APH I (Sub I), Ltd. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Initial Business Combination”). The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). On December 23, 2020, the Company formally changed its name to Apollo Strategic Growth Capital II. At September 30, 2021, the Company had not commenced any operations. All activity for the period from October 10, 2008 through September 30, 2021 relates to the Company’s formation and the initial public offering (the “Public Offering”) described below and search for a target company. The Company will not generate any operating revenues until after completion of its Initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the net proceeds derived from the Public Offering. Sponsor and Public Offering On February 12, 2021, the Company consummated the Public Offering of 69,000,000 units (“Units” and, with respect to the Company’s Class A ordinary shares, $0.00025 par value per share included in the Units being offered, the “Public Shares”), including the issuance of 9,000,000 Units as a result of the underwriters’ full exercise of their over-allotment option, generating gross proceeds of $690,000,000, which is described in Note 3. The Company’s sponsor is APSG Sponsor II, L.P., a Cayman Islands limited partnership (the “Sponsor”). The Company intends to finance its Initial Business Combination with proceeds from the $690,000,000 Public Offering and the $15,600,000 private placement (Note 4). Upon the closing of the Public Offering and the private placement, $690,000,000 was placed in a trust account (the “Trust Account”) (discussed below). Simultaneously to the Public Offering the Sponsor purchased an aggregate of 10,400,000 warrants (the “Private Placement Warrants”) at a purchase price of $1.50 per warrant, or approximately $15,600,000 in the aggregate, in a private placement simultaneously with the closing of the Public Offering (the “Private Placement”). The transaction costs amounted to $40,561,088 consisting of $13,800,000 of underwriting fees, $24,150,000 of deferred underwriting fees payable (which are held in the Trust Account with Continental Stock Transfer and Trust Company acting as trustee) and $1,116,690 of Public Offering costs. Of these costs $39,066,690 were charged to additional paid-in capital upon completion of the Public Offering. In addition, $1,494,398 were allocated to the Public Warrants and Private Placement Warrants and were included in the statements of operations as a component of other income/(expense). Cash of $1,585,629 was held outside of the Trust Account on September 30, 2021 and is available for working capital purposes. As described in Note 6, the $24,150,000 deferred underwriting fee payable is contingent upon the consummation of an Initial Business Combination by February 12, 2023 (or by May 12, 2023 if the Company has executed a letter of intent, agreement in principle or definitive agreement for the Initial Business Combination by February 12, 2023) (the “Completion Window”). Trust Account The proceeds held in the Trust Account are invested only in U.S. government securities with a maturity of one hundred eighty (180) days or less or in money market funds that meet certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended, and that invest only in direct U.S. government treasury obligations, as determined by the Company. Funds will remain in the Trust Account until the earlier of (i) the consummation of the Initial Business Combination or (ii) the distribution of the Trust Account proceeds as described below. The remaining proceeds outside the Trust Account may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses. At September 30, 2021, the proceeds of the Public Offering of $690,063,006 were held in U.S. government securities, as specified above. The Company’s fourth amended and restated memorandum and articles of association provides that, other than the withdrawal of interest to pay our tax obligations (the “Permitted Withdrawals”), and up to $100,000 of interest to pay dissolution expenses none of the funds held in the Trust Account will be released until the earliest of: (i) the completion of the Initial Business Combination; (ii) the redemption of any Public Shares sold in the Public Offering that have been properly tendered in connection with a shareholder vote to amend the Company’s fourth amended and restated memorandum and articles of association to affect the substance or timing of its obligation to redeem 100% of such Public Shares if it has not consummated an Initial Business Combination within the Completion Window; or (iii) the redemption of 100% of the Public Shares if the Company is unable to complete an Initial Business Combination within the Completion Window. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders. Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds of the Public Offering are intended to be generally applied toward consummating an Initial Business Combination. The Initial Business Combination must occur with one or more target businesses that together have a fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting discounts and commissions and taxes payable on interest earned on the Trust Account) at the time of the agreement to enter into the Initial Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect an Initial Business Combination. The Company, after signing a definitive agreement for an Initial Business Combination, will either (i) seek shareholder approval of the Initial Business Combination at a meeting called for such purpose in connection with which shareholders may seek to redeem their Public Shares, regardless of whether they vote for or against the Initial Business Combination, for cash equal to their pro rata share of the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the Initial Business Combination, including interest not previously released to the Company to make Permitted Withdrawals or (ii) provide shareholders with the opportunity to sell their Public Shares to the Company by means of a tender offer (and thereby avoid the need for a shareholder vote) for an amount in cash equal to their pro rata share of the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the Initial Business Combination, including interest not previously released to the Company to make Permitted Withdrawals. The decision as to whether the Company will seek shareholder approval of the Initial Business Combination or will allow shareholders to sell their Public Shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek shareholder approval, unless a vote is required by law or under New York Stock Exchange (“NYSE”) rules. If the Company seeks shareholder approval, it will complete its Initial Business Combination only if a majority of the outstanding ordinary shares voted are voted in favor of the Initial Business Combination. In the event that the redemption of the Company’s Public Shares would cause its net tangible assets to be less than $5,000,001, the Company would not proceed with the redemption of its Public Shares. If the Company holds a shareholder vote or there is a tender offer for shares in connection with an Initial Business Combination, a shareholder will have the right to redeem his, her or its Public Shares for an amount in cash equal to his, her or its pro rata share of the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the Initial Business Combination, including interest not previously released to make Permitted Withdrawals. As a result, such Public Shares are recorded at redemption amount and classified as temporary equity upon the completion of the Public Offering, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “ Distinguishing Liabilities from Equity Pursuant to the Company’s fourth amended and restated memorandum and articles of association, if the Company is unable to complete the Initial Business Combination within the Completion Window, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten (10) business days thereafter subject to lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to make Permitted Withdrawals (less up to $100,000 of such net interest to pay dissolution expenses and net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors (the “Board”), dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares (as defined below in Note 5) held by them if the Company fails to complete the Initial Business Combination within the Completion Window. However, if the Sponsor or any of the Company’s directors, officers or affiliates acquires Class A ordinary shares in or after the Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete the Initial Business Combination within the prescribed time period. In the event of a liquidation, dissolution or winding up of the Company after an Initial Business Combination, the Company’s shareholders are entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of ordinary share, if any, having preference over the ordinary shares. The Company’s shareholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the ordinary shares, except that the Company will provide its shareholders with the opportunity to redeem their Public Shares for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account, upon the completion of the Initial Business Combination, subject to the limitations described herein. Going Concern Considerations, Liquidity and Capital Resources As of September 30, 2021, we had investments held in the Trust Account of $690,063,006 principally invested in U.S. government securities. Interest income on the balance in the Trust Account may be used by us to pay taxes, and to pay up to $100,000 of any dissolution expenses. In connection with the Company's assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern,” The Company intends to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, excluding the deferred underwriting commissions, to complete its Initial Business Combination. To the extent that capital stock or debt is used, in whole or in part, as consideration to complete the Initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue growth strategies. If an Initial Business Combination agreement requires the Company to use a portion of the cash in the Trust Account to pay the purchase price or requires the Company to have a minimum amount of cash at closing, the Company will need to reserve a portion of the cash in the Trust Account to meet such requirements or arrange for third-party financing. The Company is required to complete an Initial Business Combination within the Completion Window. If the Company is unable to complete an Initial Business Combination within this Completion Window, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten (10) business days thereafter, and subject to having lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the Trust Account deposits (which interest shall be net of taxes payable and less up to $100,000 to pay dissolution expenses), divided by the number of then-outstanding Public Shares, which redemption will completely extinguish the public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Board dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The underwriters have agreed to waive their rights to their deferred underwriting commissions held in the Trust Account in the event the Company does not complete an Initial Business Combination within the Completion Window and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares.

REVISION OF PREVIOUSLY ISSUED F

REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	9 Months Ended
	Sep. 30, 2021
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2 — REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS The Company has followed Accounting Standards Codification (“ ASC Distinguishing Liabilities from Equity, In September 2021, the SEC communicated its view that classification of $5,000,001 in permanent equity was not appropriate and that all public shares should be reclassified as temporary equity. This is a change from the Company’s previous accounting practice whereby as noted above it maintained shareholders’ equity of at least $5,000,001 as the Company will not redeem Class A ordinary shares that would cause the Company’s net tangible assets to be less than $5,000,001 following such redemptions. However, the Company has concluded that in light of the SEC’s recent interpretation, it will change its accounting and reflect the full amount of all redeemable Class A ordinary shares in temporary equity. In connection with the change in presentation for the Class A ordinary shares subject to possible redemption, the Company also revised its earnings per share calculation to allocate net income (loss) evenly to Class A and Class B ordinary shares. The presentation contemplates an Initial Business Combination as the most likely outcome, in which case, both classes of ordinary shares share pro rata in the income (loss) of the Company. The impact on previously issued financial statements is presented below. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As previously ​ ​ ​ ​ ​ reported Adjustments As revised February 12, 2021 sheet (Form 8-K) ​ ​ ​ Temporary equity $ 661,534,070 $ 28,465,930 $ 690,000,000 Shareholders’ equity ​ ​ ​ Class A ordinary shares ​ 712 ​ (712) ​ — Class B ordinary shares ​ 1,078 ​ — ​ 1,078 Additional paid-in capital ​ 5,031,827 ​ (5,031,827) ​ — Accumulated deficit ​ (33,607) ​ (23,433,391) ​ (23,466,998) Total shareholders’ deficit $ 5,000,010 $ (28,465,930) $ (23,465,920) ​

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation Certain information and note disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been condensed. As such, the information included in these condensed financial statements should be read in conjunction with the audited financial statements as of December 31, 2020 included in the registration statement on Form S-1 (File No. 333-251920) filed with the SEC. In the opinion of the Company's management, these condensed financial statements include all adjustments, which are only of a normal and recurring nature, necessary for a fair statement of the financial position of the Company as of September 30, 2021 and its results of operations and cash flows for the nine months ended September 30, 2021. The results of operations for the nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2021. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Offering Costs associated with a Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “ Expenses of Offering.” Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480, “ Distinguishing Liabilities from Equity. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A ordinary shares resulted in charges against additional paid-in capital and accumulated deficit. At September 30, 2021, the Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 690,000,000 Less: ​ Proceeds allocated to Public Warrants ​ ​ (26,312,460) Class A ordinary shares issuance costs ​ ​ (37,750,802) Plus: ​ ​ Accretion of carrying value to redemption value ​ ​ 64,063,262 Class A ordinary shares subject to possible redemption ​ $ 690,000,000 ​ Income Taxes ASC 740, “Income Taxes,” There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of ASC 260, “ Earnings Per Share.” period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. As of September 30, 2021 and 2020, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended Three Months Ended ​ ​ September 30, 2021 ​ September 30, 2020 ​ Class A Class B Class A Class B Basic and diluted net income per ordinary share ​ ​ ​ ​ Numerator: ​ ​ ​ ​ Allocation of net income, as adjusted ​ $ 5,245,134 ​ $ 1,311,284 ​ $ — ​ $ — Denominator: ​ ​ ​ ​ Basic and diluted weighted average shares outstanding ​ 69,000,000 ​ 17,250,000 ​ — ​ 15,000,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net income per ordinary share ​ $ 0.08 ​ $ 0.08 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Nine Months Ended Nine Months Ended ​ ​ September 30, 2021 September 30, 2020 ​ Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share ​ ​ ​ ​ Numerator: ​ ​ ​ ​ Allocation of net income (loss), as adjusted ​ $ 10,476,811 ​ $ 2,619,203 ​ $ — ​ $ (1,854) Denominator: ​ ​ ​ ​ Basic and diluted weighted average shares outstanding ​ 69,000,000 ​ 17,250,000 ​ — ​ 15,000,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net income (loss) per ordinary share ​ $ 0.15 ​ $ 0.15 ​ $ — ​ $ (0.00) ​ Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “ Derivatives and Hedging. Fair Value Measurement, Warrant Instruments The Company accounts for the Warrants issued in connection with the Public Offering and Private Placement in accordance with the guidance contained in ASC 815, “ Derivatives and Hedging, Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update ("ASU") No. 2020-06, “ Debt -Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging --Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity ("ASU 2020-06")”, Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	9 Months Ended
	Sep. 30, 2021
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 4 — INITIAL PUBLIC OFFERING Pursuant to the Public Offering, the Company sold 69,000,000 Units at a purchase price of $10.00 per Unit, including the issuance of 9,000,000 Units as a result of the underwriters' full exercise of their over-allotment option, generating gross proceeds to the Company in the amount of $690,000,000. Each Unit consists of one share of the Company’s Class A ordinary shares, par value $0.00025 per share (the “Class A ordinary shares”), and one - fifth of one redeemable warrant of the Company (each whole warrant, a “Public Warrant”), with each Public Warrant entitling the holder thereof to purchase one whole Class A ordinary share at a price of $11.50 per share, subject to adjustment.

PRIVATE PLACEMENT

PRIVATE PLACEMENT	9 Months Ended
	Sep. 30, 2021
PRIVATE PLACEMENT
PRIVATE PLACEMENT	NOTE 5 — PRIVATE PLACEMENT Simultaneously with the closing of the Public Offering, the Company consummated the Private Placement of an aggregate of 10,400,000 Private Placement Warrants to the Sponsor at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company in the amount of $15,600,000. A portion of the proceeds from the Private Placement Warrants was added to the proceeds from the Public Offering held in the Trust Account. If the Company does not complete an Initial Business Combination within the Completion Window, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will be worthless. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the Initial Business Combination.

RELATED PARTIES

RELATED PARTIES	9 Months Ended
	Sep. 30, 2021
RELATED PARTIES
RELATED PARTIES	NOTE 6 — RELATED PARTIES Founder Shares In October 2008, the Company was formed by Apollo Principal Holdings III, L.P. (“Holdings”), at which point, one ordinary share was issued in exchange for the payment of operating and formation expenses of the Company. In December 2020, Holdings transferred its ownership in the Company, consisting of one ordinary share, to the Sponsor for no consideration. On December 23, 2020, the Company completed a share split of its ordinary shares and, as a result, 11,500,000 shares of the Company’s Class B ordinary shares, par value $0.0000625 per share, were outstanding (the “Founder Shares”). In February 2021, the Company subdivided its authorized and outstanding founder shares, resulting in 17,250,000 shares of the Company’s Class B ordinary shares outstanding. The share amounts have been retroactively restated to account for the share split. The Founder Shares represent 20.0% of the Company’s issued and outstanding shares. The Founder Shares are identical to the Class A ordinary shares included in the Units sold in the Public Offering except that the Founder Shares are Class B ordinary shares which automatically convert into Class A ordinary shares at the time of the Company’s Initial Business Combination and are subject to certain transfer restrictions, as described in more detail below. The number of Founder Shares issued in the share split was determined based on the expectation that the total size of the Public Offering would be a maximum of 69,000,000 Units if the underwriters’ over-allotment option was exercised in full, and therefore that such Founder Shares would represent 20% of the issued and outstanding ordinary shares after the Public Offering. The holders of the Founder Shares agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the Initial Business Combination or (B) subsequent to the Initial Business Combination, (x) if the last sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their shares of ordinary shares for cash, securities or other property. In January 2020, 25,000 Founder Shares were purchased by each of our three independent directors at a purchase price of $0.002174 per share. The independent directors paid $163.05 in the aggregate for 75,000 shares. On February 3, 2021, our Sponsor surrendered 8,550,000 founder shares to continue to hold 14,300,000 founder shares and each of our independent directors surrendered 25,000 founder shares to continue to hold 25,000 founder shares. On February 12, 2021, the Company also subdivided our authorized and outstanding founder shares and the Sponsor surrendered 11,425,000 founder shares to continue to hold 17,175,000 founder shares while each of our independent directors surrendered 25,000 founder shares to continue to hold 25,000 shares. Related Party Loans On December 28, 2020, the Sponsor agreed to loan the Company an aggregate of up to $750,000 to cover expenses related to the Proposed Public Offering pursuant to an unsecured promissory note (the “Promissory Note”). This Promissory Note bears interest at a rate of 0.15% per annum and is payable on September 30, 2021. As of December 31, 2020, the Company had not borrowed on the Promissory Note and the Promissory Note expired upon the closing of the Public Offering on February 12, 2021. In addition, in order to finance transaction costs in connection with an Initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company's officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes an Initial Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of the funds held outside the Trust Account. In the event that an Initial Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consumptions of an Initial Business Combination or, at the lenders' discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants. On March 1, 2021, the Sponsor agreed to loan the Company an aggregate of up to $1,500,000 to cover expenses related to the Public Offering pursuant to an unsecured promissory note (the “March Note”). The March Note bears interest at a rate of 0.11% per annum and is payable on the date of an Initial Business Combination or the liquidation of the Company. As of September 30, 2021, the outstanding balance under the March Note was $1,500,000. On September 14, 2021, the Sponsor executed an unsecured promissory note (the “September Note”) to loan the Company an aggregate principal amount of $1,500,000. The September Note bears interest at a rate of 0.17% per annum and is payable on the earlier of an Initial Business Combination or the liquidation of the Company. As of September 30, 2021, the outstanding balance on the September Note was $1,500,000. Advances from Related Parties Affiliates of the Sponsor paid certain administrative expenses and offering costs on behalf of the Company. These advances are due on demand and are non-interest bearing. For the period from October 10, 2008 (inception) through September 30, 2021, the related parties paid $249,995 of offering costs and other expenses on behalf of the Company which were repaid during the six months ended September 30, 2021. As of September 30, 2021 and December 31, 2020, there was $0 and $50,186 due to the related parties, respectively. Administrative Service Fee Commencing on the date the Units are first listed on the NYSE, the Company entered into an agreement with the Sponsor and has agreed to pay the Sponsor a total of $16,667 per month for office space, utilities and secretarial and administrative support for up to 27 months. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. During the three and nine months ended September 30, 2021, the Company recorded $50,001 and $126,788, respectively, pursuant to this agreement.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2021
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 7 — COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Registration Rights The holders of the Founder Shares, Private Placement Warrants and Public Warrants that may be issued upon conversion of Working Capital Loans, if any, (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and Public Warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement. The holders of these securities are entitled to demand that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of an Initial Business Combination. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 30-day option from the date of the final prospectus to purchase up to 9,000,000 additional Units to cover over-allotments, if any, at the Public Offering price less the underwriting discounts and commissions. The underwriters elected to exercise the over-allotment at closing. Upon the closing of the IPO and the full over-allotment, the underwriters were entitled to an underwriting discount of $0.20 per unit, or $13,800,000, after the underwriters’ exercised their over-allotment option in full, which was paid in the aggregate upon the closing of the Public Offering. In addition, the underwriters are entitled to an underwriting discount of $0.35 per unit, or $24,150,000 in the aggregate is payable to the underwriters for deferred underwriting commissions. The deferred fee becomes payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes an Initial Business Combination, subject to the terms of the underwriting agreement for the offering.

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	9 Months Ended
	Sep. 30, 2021
SHAREHOLDERS' EQUITY
SHAREHOLDERS' EQUITY	NOTE 8 — SHAREHOLDERS’ EQUITY Preferred Shares The Company is authorized to issue 1,000,000 shares of preferred shares with a par value of $0.00025 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2021 and December 31, 2020, there were no preferred shares issued or outstanding. Ordinary Shares The authorized ordinary shares of the Company include up to 180,000,000 Class A ordinary shares and 46,000,000 Class B ordinary shares. If the Company enters into an Initial Business Combination, it may (depending on the terms of such an Initial Business Combination) be required to increase the number of Class A ordinary shares which the Company is authorized to issue at the same time as the Company’s shareholders vote on the Initial Business Combination to the extent the Company seeks shareholder approval in connection with the Initial Business Combination. Holders of the Company’s ordinary shares are entitled to one vote for each ordinary share. As of September 30, 2021, there were 69,000,000 Class A ordinary shares subject to possible conversion that were classified as temporary equity in the accompanying condensed balance sheets. The Class B ordinary shares will automatically convert into our Class A ordinary shares at the time of completion of our Initial Business Combination on a one-for-one basis, subject to adjustment for share splits, dividends, reorganizations, recapitalizations and the like and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Public Offering and related to the closing of the Initial Business Combination, the ratio at which Class B ordinary shares will convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all ordinary shares outstanding upon the completion of the Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the Initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the business combination). As of September 30, 2021 and December 31, 2020, there were 17,250,000 shares issued outstanding

WARRANTS

WARRANTS	9 Months Ended
	Sep. 30, 2021
WARRANTS
WARRANTS	NOTE 9 — WARRANTS Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of an Initial Business Combination or (b) 12 months from the closing of the Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than fifteen (15) business days after the closing of an Initial Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the ordinary shares issuable upon exercise of the Public Warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. Notwithstanding the foregoing, if the Company’s ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under the Securities Act, the Company, at its option, may require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement. The Public Warrants will expire five years after the completion of an Initial Business Combination or earlier upon the Company’s redemption or liquidation. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of an Initial Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption; and ● if, and only if, the last reported closing price of the Company’s ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. If, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and a current prospectus relating to those ordinary shares is available throughout the 30-day trading period referred to above. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as will be described in the warrant agreement. The exercise price and number of the ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete an Initial Business Combination within the Completion Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. The Company accounts for the 24,200,000 warrants issued in connection with the Public Offering (including 13,800,000 Public Warrants and 10,400,000 Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Public Offering. Accordingly, the Company classifies each warrant as a liability at its fair value and the warrants will be allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation up until separation for the Public Warrants (subsequent to separation, the public warrants will be valued using publicly available trading price) and a modified Black-Scholes model for the Private Placement Warrants. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statements of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Sep. 30, 2021
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 10 — FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820, “ Fair Value Measurement, The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets and liabilities that are measured at fair value at September 30, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ Description ​ Level September 30, 2021 Assets: ​ Marketable securities held in Trust Account 1 ​ $ 690,063,006 ​ ​ ​ ​ ​ ​ Liabilities: ​ Warrant Liability – Private Placement Warrants ​ 3 ​ $ 9,693,182 Warrant Liability – Public Warrants 1 ​ $ 12,834,000 ​ The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within liabilities on the balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the statement of operations. Upon consummation of the Public Offering, the Company used a Monte Carlo simulation model to value the Public Warrants and a modified Black-Scholes model to value the Private Placement Warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one share of Class A ordinary shares and one-fifth of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of Class B ordinary shares, first to the Warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A ordinary shares subject to possible redemption (temporary equity), Class A ordinary shares (permanent equity) and Class B ordinary shares (permanent equity) based on their relative fair values at the initial measurement date. At the initial measurement date, the Warrants were classified within Level 3 of the fair value hierarchy at the measurement dates due to the use of unobservable inputs. As of September 30, 2021 the Public Warrants were valued using the publicly available price for the Warrant and are classified as Level 1 on the Fair Value Hierarchy. At September 30, 2021, the Company used a modified Black-Scholes model to value the Private Placement Warrants. The Company relied upon the implied volatility of the Public Warrants and the closing stock price at September 30, 2021 to estimate the volatility for the Private Placement Warrants. At September 30, 2021, the Private Placement Warrants were classified within Level 3 of the Fair Value Hierarchy at the measurement dates due to the use of unobservable inputs. The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and nine months ended September 30, 2021: ​ ​ ​ ​ ​ ​ Fair Value ​ ​ Measurement Using ​ Level 3 Inputs Total Balance, June 30, 2021 ​ $ 13,351,520 Change in fair value of derivative liabilities ​ (3,658,338) Balance, September 30, 2021 ​ $ 9,693,182 ​ ​ ​ ​ ​ ​ Fair Value ​ ​ Measurement Using ​ ​ Level 3 Inputs Total Balance, December 31, 2020 ​ $ — Change in fair value of derivative liabilities ​ (19,511,278) Transfer to Level 1 ​ ​ (17,388,000) Derivative liabilities recorded on issuance of derivative warrants ​ 46,592,460 Balance, September 30, 2021 ​ $ 9,693,182 ​ As of September 30, 2021 and February 12, 2021, the fair value of the derivative feature of the warrants was calculated using the following weighted average assumptions: ​ ​ ​ ​ ​ ​ ​ ​ February 12, 2021 September 30, 2021 ​ Risk-free interest rate ​ 0.66 % 1.12 % Expected life 6.0 years 5.68 years Expected volatility of underlying shares 18.0-27.0 % 14.0 % Dividends 0 % 0 % ​ As of September 30, 2021 and December 31, 2020, the derivative liability was $22,527,182 and $0, respectively. In addition, for the three and nine months ended September 30, 2021, the Company recorded $8,212,338 and $19,385,278, respectively, as a gain on the change in fair value of the derivative warrants on the statements of operations. Upon issuance of the Private Placement Warrants, the Company recorded a loss of $4,680,000 for the excess fair value of the derivative warrants over the proceeds received from the sale of the Private Placement Warrants which is included in the change in fair value of the derivative liabilities on the condensed statement of operations.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2021
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 11  —  SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation Certain information and note disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been condensed. As such, the information included in these condensed financial statements should be read in conjunction with the audited financial statements as of December 31, 2020 included in the registration statement on Form S-1 (File No. 333-251920) filed with the SEC. In the opinion of the Company's management, these condensed financial statements include all adjustments, which are only of a normal and recurring nature, necessary for a fair statement of the financial position of the Company as of September 30, 2021 and its results of operations and cash flows for the nine months ended September 30, 2021. The results of operations for the nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2021.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Offering Costs associated with a Public Offering	Offering Costs associated with a Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “ Expenses of Offering.”
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480, “ Distinguishing Liabilities from Equity. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A ordinary shares resulted in charges against additional paid-in capital and accumulated deficit. At September 30, 2021, the Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 690,000,000 Less: ​ Proceeds allocated to Public Warrants ​ ​ (26,312,460) Class A ordinary shares issuance costs ​ ​ (37,750,802) Plus: ​ ​ Accretion of carrying value to redemption value ​ ​ 64,063,262 Class A ordinary shares subject to possible redemption ​ $ 690,000,000
Income Taxes	Income Taxes ASC 740, “Income Taxes,” There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of ASC 260, “ Earnings Per Share.” period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. As of September 30, 2021 and 2020, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended Three Months Ended ​ ​ September 30, 2021 ​ September 30, 2020 ​ Class A Class B Class A Class B Basic and diluted net income per ordinary share ​ ​ ​ ​ Numerator: ​ ​ ​ ​ Allocation of net income, as adjusted ​ $ 5,245,134 ​ $ 1,311,284 ​ $ — ​ $ — Denominator: ​ ​ ​ ​ Basic and diluted weighted average shares outstanding ​ 69,000,000 ​ 17,250,000 ​ — ​ 15,000,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net income per ordinary share ​ $ 0.08 ​ $ 0.08 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Nine Months Ended Nine Months Ended ​ ​ September 30, 2021 September 30, 2020 ​ Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share ​ ​ ​ ​ Numerator: ​ ​ ​ ​ Allocation of net income (loss), as adjusted ​ $ 10,476,811 ​ $ 2,619,203 ​ $ — ​ $ (1,854) Denominator: ​ ​ ​ ​ Basic and diluted weighted average shares outstanding ​ 69,000,000 ​ 17,250,000 ​ — ​ 15,000,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net income (loss) per ordinary share ​ $ 0.15 ​ $ 0.15 ​ $ — ​ $ (0.00)
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “ Derivatives and Hedging. Fair Value Measurement,
Warrant Instruments	Warrant Instruments The Company accounts for the Warrants issued in connection with the Public Offering and Private Placement in accordance with the guidance contained in ASC 815, “ Derivatives and Hedging,
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
Recent Accounting Standards	Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update ("ASU") No. 2020-06, “ Debt -Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging --Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity ("ASU 2020-06")”, Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

REVISION OF PREVIOUSLY ISSUED_2

REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)	9 Months Ended
	Sep. 30, 2021
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
Summary of impact on previously issued financial statements	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As previously ​ ​ ​ ​ ​ reported Adjustments As revised February 12, 2021 sheet (Form 8-K) ​ ​ ​ Temporary equity $ 661,534,070 $ 28,465,930 $ 690,000,000 Shareholders’ equity ​ ​ ​ Class A ordinary shares ​ 712 ​ (712) ​ — Class B ordinary shares ​ 1,078 ​ — ​ 1,078 Additional paid-in capital ​ 5,031,827 ​ (5,031,827) ​ — Accumulated deficit ​ (33,607) ​ (23,433,391) ​ (23,466,998) Total shareholders’ deficit $ 5,000,010 $ (28,465,930) $ (23,465,920)

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Summary of reconciliation of common stock subject to possible redemption	​ ​ ​ ​ ​ Gross proceeds $ 690,000,000 Less: ​ Proceeds allocated to Public Warrants ​ ​ (26,312,460) Class A ordinary shares issuance costs ​ ​ (37,750,802) Plus: ​ ​ Accretion of carrying value to redemption value ​ ​ 64,063,262 Class A ordinary shares subject to possible redemption ​ $ 690,000,000
Reconciliation of net income (loss) per ordinary share	The following table reflects the calculation of basic and diluted net income (loss) per ordinary share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended Three Months Ended ​ ​ September 30, 2021 ​ September 30, 2020 ​ Class A Class B Class A Class B Basic and diluted net income per ordinary share ​ ​ ​ ​ Numerator: ​ ​ ​ ​ Allocation of net income, as adjusted ​ $ 5,245,134 ​ $ 1,311,284 ​ $ — ​ $ — Denominator: ​ ​ ​ ​ Basic and diluted weighted average shares outstanding ​ 69,000,000 ​ 17,250,000 ​ — ​ 15,000,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net income per ordinary share ​ $ 0.08 ​ $ 0.08 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Nine Months Ended Nine Months Ended ​ ​ September 30, 2021 September 30, 2020 ​ Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share ​ ​ ​ ​ Numerator: ​ ​ ​ ​ Allocation of net income (loss), as adjusted ​ $ 10,476,811 ​ $ 2,619,203 ​ $ — ​ $ (1,854) Denominator: ​ ​ ​ ​ Basic and diluted weighted average shares outstanding ​ 69,000,000 ​ 17,250,000 ​ — ​ 15,000,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net income (loss) per ordinary share ​ $ 0.15 ​ $ 0.15 ​ $ — ​ $ (0.00)

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Sep. 30, 2021
FAIR VALUE MEASUREMENTS
Schedule of Company's assets and liabilities that are measured at fair value on a recurring basis	​ ​ ​ ​ ​ ​ ​ Description ​ Level September 30, 2021 Assets: ​ Marketable securities held in Trust Account 1 ​ $ 690,063,006 ​ ​ ​ ​ ​ ​ Liabilities: ​ Warrant Liability – Private Placement Warrants ​ 3 ​ $ 9,693,182 Warrant Liability – Public Warrants 1 ​ $ 12,834,000
Schedule of the changes in fair value, including net transfers in all financial assets and liabilities	​ ​ ​ ​ ​ ​ Fair Value ​ ​ Measurement Using ​ Level 3 Inputs Total Balance, June 30, 2021 ​ $ 13,351,520 Change in fair value of derivative liabilities ​ (3,658,338) Balance, September 30, 2021 ​ $ 9,693,182 ​ ​ ​ ​ ​ ​ Fair Value ​ ​ Measurement Using ​ ​ Level 3 Inputs Total Balance, December 31, 2020 ​ $ — Change in fair value of derivative liabilities ​ (19,511,278) Transfer to Level 1 ​ ​ (17,388,000) Derivative liabilities recorded on issuance of derivative warrants ​ 46,592,460 Balance, September 30, 2021 ​ $ 9,693,182
Schedule of the fair value of the derivative feature of the warrants	​ ​ ​ ​ ​ ​ ​ ​ February 12, 2021 September 30, 2021 ​ Risk-free interest rate ​ 0.66 % 1.12 % Expected life 6.0 years 5.68 years Expected volatility of underlying shares 18.0-27.0 % 14.0 % Dividends 0 % 0 %

DESCRIPTION OF ORGANIZATION, _2

DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN (Details)	Feb. 12, 2021USD ($)$ / sharesshares	Sep. 30, 2021USD ($)$ / sharesshares
Subsidiary, Sale of Stock [Line Items]
Proceeds from sale of Private Placement Warrants		$ 15,600,000
Transaction Costs		40,561,088
Underwriting fees		13,800,000
Deferred underwriting fee payable		24,150,000
Other offering costs		1,494,398
Public offering costs		1,116,690
Cash held outside the Trust Account		1,585,629
Contingent underwriting fee payable related business combination		24,150,000
Payments for investment of cash in Trust Account		$ 690,063,006
Condition for future business combination use of proceeds percentage		100
Condition for future business combination threshold Percentage Ownership		100
Condition for future business combination threshold Net Tangible Assets		$ 5,000,001
Redemption limit percentage without prior consent		80
Maximum Allowed Dissolution Expenses		$ 100,000
Public Warrants
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares		13,800,000
Purchase price, per unit | $ / shares		$ 0.01
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares	69,000,000	24,200,000
Purchase price, per unit | $ / shares	$ 10
Proceeds from issuance initial public offering	$ 690,000,000	$ 690,063,006
Other costs		$ 39,066,690
Initial Public Offering | Public Warrants
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares	0.00025
Private Placement | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Sale of Private Placement Warrants (in shares) | shares		10,400,000
Price of warrant | $ / shares		$ 1.50
Proceeds from sale of Private Placement Warrants		$ 15,600,000
Cash held outside the Trust Account		$ 690,000,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares	9,000,000	9,000,000
APSG Sponsor II, L.P.
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance initial public offering		$ 690,000,000

REVISION OF PREVIOUSLY ISSUED_3

REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - USD ($)	Sep. 30, 2021	Jun. 30, 2021	Feb. 12, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Minimum shareholder's equity	$ 5,000,001
Minimum net tangible assets	5,000,001
Reclassification of permanent equity into temporary equity	5,000,001
Balance sheet as of February 12, 2021
Temporary equity			$ 690,000,000
Additional paid-in capital				$ 32,529
Accumulated deficit	(50,966,622)		(23,466,998)	(31,903)
Total stockholders' deficit	(50,965,544)	$ (57,521,962)	(23,465,920)	1,704	$ 1,704	$ 1,704	$ 1,854
Class A Common Stock
Balance sheet as of February 12, 2021
Temporary equity	690,000,000
Class A Common Stock Subject to Redemption
Balance sheet as of February 12, 2021
Temporary equity	690,000,000
Class B Common Stock
Balance sheet as of February 12, 2021
Ordinary shares	$ 1,078		1,078	$ 1,078
As Previously Reported
Balance sheet as of February 12, 2021
Temporary equity			661,534,070
Additional paid-in capital			5,031,827
Accumulated deficit			(33,607)
Total stockholders' deficit			5,000,010
As Previously Reported | Class A Common Stock
Balance sheet as of February 12, 2021
Ordinary shares			712
As Previously Reported | Class B Common Stock
Balance sheet as of February 12, 2021
Ordinary shares			1,078
Adjustments
Balance sheet as of February 12, 2021
Temporary equity			28,465,930
Additional paid-in capital			(5,031,827)
Accumulated deficit			(23,433,391)
Total stockholders' deficit			(28,465,930)
Adjustments | Class A Common Stock
Balance sheet as of February 12, 2021
Ordinary shares			$ (712)

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	9 Months Ended
	Sep. 30, 2021USD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Federal depository insurance coverage	$ 250,000
Other offering costs	1,494,398
Underwriter discount	37,950,000
Unrecognized tax benefits	$ 0

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A Ordinary Shares Subject to Possible Redemption (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Feb. 12, 2021	Dec. 31, 2020
Gross proceeds	$ 690,000,000
Proceeds allocated to Public Warrants	(26,312,460)
Accretion of carrying value to redemption value	64,063,262
Class A ordinary shares subject to possible redemption		$ 690,000,000
Class A Common Stock
Class A ordinary shares issuance costs	(37,750,802)
Class A ordinary shares subject to possible redemption	$ 690,000,000
Class A ordinary shares subject to possible redemption (in shares)	69,000,000		69,000,000

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) per ordinary share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Class A Common Stock
Numerator:
Allocation of net income (loss), as adjusted	$ 5,245,134		$ 10,476,811
Denominator:
Basic and diluted weighted average shares outstanding	69,000,000		69,000,000
Basic and diluted net income (loss) per ordinary share	$ 0.08	$ 0	$ 0.15	$ 0
Class B Common Stock
Numerator:
Allocation of net income (loss), as adjusted	$ 1,311,284		$ 2,619,203	$ (1,854)
Denominator:
Basic and diluted weighted average shares outstanding	17,250,000	15,000,000	17,250,000	15,000,000
Basic and diluted net income (loss) per ordinary share	$ 0.08	$ 0	$ 0.15	$ 0

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) - USD ($)	Feb. 12, 2021	Sep. 30, 2021	Dec. 31, 2020
Public Warrants
Subsidiary, Sale of Stock [Line Items]
Number of units issued		13,800,000
Purchase price, per unit		$ 0.01
Class A Common Stock
Subsidiary, Sale of Stock [Line Items]
Common Stock, Par or Stated Value Per Share		$ 0.00025	$ 0.00025
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units issued	69,000,000	24,200,000
Purchase price, per unit	$ 10
Proceeds from issuance initial public offering	$ 690,000,000	$ 690,063,006
Number of shares in a unit	9,000,000
Initial Public Offering | Public Warrants
Subsidiary, Sale of Stock [Line Items]
Number of units issued	0.00025
Number of warrants in a unit	0.2
Number of shares issuable per warrant	1
Exercise price of warrants	$ 11.50
Initial Public Offering | Class A Common Stock
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance initial public offering	$ 690,000,000
Common Stock, Par or Stated Value Per Share	$ 0.00025
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units issued	9,000,000	9,000,000

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details)	9 Months Ended
	Sep. 30, 2021USD ($)$ / sharesshares
Subsidiary, Sale of Stock [Line Items]
Aggregate purchase price	$ 15,600,000
Private Placement | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued | shares	10,400,000
Price of warrants | $ / shares	$ 1.50
Aggregate purchase price	$ 15,600,000

RELATED PARTIES - Founder Share

RELATED PARTIES - Founder Shares (Details)	1 Months Ended	9 Months Ended
	Jan. 31, 2020$ / sharesshares	Sep. 30, 2021D$ / sharesshares	Mar. 01, 2021	Feb. 28, 2021shares	Feb. 12, 2021shares	Feb. 03, 2021shares	Dec. 31, 2020$ / sharesshares	Dec. 23, 2020$ / sharesshares
Related Party Transaction [Line Items]
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders		20.00%
Private Placement Warrants | Private Placement
Related Party Transaction [Line Items]
Price of warrant | $ / shares		$ 1.50
Number of warrants to purchase shares issued		10,400,000
Class B Common Stock
Related Party Transaction [Line Items]
Ordinary shares outstanding		17,250,000					17,250,000
Common shares, par value (in dollars per share) | $ / shares		$ 0.0000625					$ 0.0000625
Sponsor
Related Party Transaction [Line Items]
Surrendered founder shares					11,425,000	8,550,000
Note bears interest rate			0.11%
Founder Shares
Related Party Transaction [Line Items]
Holding of shares					17,175,000	14,300,000
Independent Directors
Related Party Transaction [Line Items]
Number of shares issued	75,000
Number of independent directors	3
Purchase price, per unit | $ / shares	$ 163.05
Independent Directors | Sponsor
Related Party Transaction [Line Items]
Surrendered founder shares					25,000	25,000
Independent Directors | Founder Shares
Related Party Transaction [Line Items]
Holding of shares					25,000	25,000
Founder Shares | Class B Common Stock
Related Party Transaction [Line Items]
Ordinary shares outstanding				17,250,000				11,500,000
Common shares, par value (in dollars per share) | $ / shares								$ 0.0000625
Aggregate number of shares owned		69,000,000
Founder Shares | Sponsor | Class B Common Stock
Related Party Transaction [Line Items]
Shares subject to forfeiture				20
Restrictions on transfer period of time after business combination completion		1 year
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares		$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D		20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D		30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences		150 days
Founder Shares | Independent Directors
Related Party Transaction [Line Items]
Price of warrant | $ / shares	$ 0.002174
Number of shares issued	25,000

RELATED PARTIES - Additional In

RELATED PARTIES - Additional Information (Details) - USD ($)	Sep. 14, 2021	Dec. 28, 2020	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2021	Mar. 01, 2021	Dec. 31, 2020
Related Party Transaction [Line Items]
Repayment of promissory note - related party				$ 226,305
Amount borrowed				3,000,000
Due to Related Parties			$ 0	$ 0	$ 0		$ 50,186
Threshold period for which expenses are paid				27 months
Outstanding balance			1,500,000	$ 1,500,000	1,500,000
Working capital loans warrant
Related Party Transaction [Line Items]
Principle amount of promissory note		$ 1,500,000
Promissory Note with Related Party
Related Party Transaction [Line Items]
Principle amount of promissory note						$ 1,500,000
Related Party Loans
Related Party Transaction [Line Items]
Expenses incurred		$ 750,000
Interest rate				0.15%
Outstanding balance of related party note							$ 0
Advances From Related Parties
Related Party Transaction [Line Items]
Offering costs and other expenses					$ 249,995
Administrative Services Agreement
Related Party Transaction [Line Items]
Expenses per month				$ 16,667
Expenses incurred			$ 50,001	$ 126,788
September Note
Related Party Transaction [Line Items]
Interest rate	0.17%
Principle amount of promissory note	$ 1,500,000
Outstanding balance	$ 1,500,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	Feb. 12, 2021	Sep. 30, 2021
Loss Contingencies [Line Items]
Underwriting cash discount per unit		$ 0.20
Aggregate underwriter cash discount		$ 13,800,000
Deferred fee per unit		$ 0.35
Aggregate deferred underwriting fee payable		$ 24,150,000
Over-allotment option
Loss Contingencies [Line Items]
Number of units issued	9,000,000	9,000,000

SHAREHOLDERS' EQUITY - Preferre

SHAREHOLDERS' EQUITY - Preferred Stock Shares (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
SHAREHOLDERS' EQUITY
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred stock, par value, (per share)	$ 0.00025	$ 0.00025
Preferred shares par value	$ 0.00025	$ 0.00025
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

SHAREHOLDERS' EQUITY - Common S

SHAREHOLDERS' EQUITY - Common Stock Shares (Details)	Sep. 30, 2021Voteshares	Dec. 31, 2020shares
Class of Stock [Line Items]
Converted basis of ordinary shares outstanding	20.00%
Class A Common Stock
Class of Stock [Line Items]
Increased ordinary shares authorized	180,000,000	180,000,000
Class A common stock subject to possible redemption, outstanding (in shares)	69,000,000	69,000,000
Common shares, shares issued (in shares)	0	0
Ordinary shares outstanding	0	0
Class A Common Stock Subject to Redemption
Class of Stock [Line Items]
Class A common stock subject to possible redemption, outstanding (in shares)	69,000,000	0
Class A Common Stock Not Subject to Redemption
Class of Stock [Line Items]
Common shares, votes per share | Vote	1
Class A common stock subject to possible redemption, outstanding (in shares)	69,000,000
Class B Common Stock
Class of Stock [Line Items]
Increased ordinary shares authorized	46,000,000	46,000,000
Common shares, shares issued (in shares)	17,250,000	17,250,000
Ordinary shares outstanding	17,250,000	17,250,000

WARRANTS (Details)

WARRANTS (Details) - USD ($)	Feb. 12, 2021	Sep. 30, 2021
Warrants liabilities.
Weighted average trading days		20 days
Ordinary shares exercisable		$ 18
Public warrants expire		30 days
Warrant liabilities		$ 22,527,182
Minimum
Warrants liabilities.
Weighted average trading days		30 days
Initial Public Offering
Warrants liabilities.
Purchase price, per unit	$ 10
Number of units issued	69,000,000	24,200,000
Public Warrants
Warrants liabilities.
Purchase price, per unit		$ 0.01
Number of units issued		13,800,000
Public Warrants | Initial Public Offering
Warrants liabilities.
Number of units issued	0.00025
Private Placement
Warrants liabilities.
Number of units issued		10,400,000

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Assets:
Marketable securities held in Trust Account	$ 690,063,006
Liabilities:
Derivative warrant liability	22,527,182	$ 0
Level 1 | Recurring
Assets:
Marketable securities held in Trust Account	690,063,006
Level 1 | Recurring | Public Warrants
Liabilities:
Derivative warrant liability	12,834,000
Level 3 | Recurring | Private Placement Warrants
Liabilities:
Derivative warrant liability	$ 9,693,182

FAIR VALUE MEASUREMENTS - Chang

FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details) - Level 3 - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	$ 13,351,520	$ 0
Change in fair value of derivative warrants	(3,658,338)	(19,511,278)
Transfer to Level 1		(17,388,000)
Derivative liabilities recorded on issuance of derivative warrants		46,592,460
Ending Balance	$ 9,693,182	$ 9,693,182

FAIR VALUE MEASUREMENTS - Level

FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details)	3 Months Ended	9 Months Ended
	Sep. 30, 2021USD ($)	Sep. 30, 2021USD ($)	Feb. 12, 2021	Dec. 31, 2020USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative warrant liability	$ 22,527,182	$ 22,527,182		$ 0
Change in fair value of derivative liabilities	(8,212,338)	(19,385,278)
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Change in fair value of derivative liabilities	$ 8,212,338	19,385,278
Loss on Derivative		$ 4,680,000
Risk-free interest rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	1.12	1.12	0.66
Expected life of grants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	5.68	5.68	6
Expected volatility of underlying shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	14	14
Dividends
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	0	0	0
Maximum | Expected volatility of underlying shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input			27
Minimum | Expected volatility of underlying shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input			18